Independent research & country-by-country guides · Information is not a substitute for medical care
Research · Compare · Explore
GLP1ASIA · INFORMATION CENTER

GLP-1 regulations across Asia

Regulatory statuses differ by medicine, brand, indication, jurisdiction and date. Start from the official authority.

Official regulatory portals

Follow the country authority to verify current products, registration notices and warnings. These links are source pointers, not assertions of approval.

CountryAuthorityOfficial source
ThailandThailand FDAVisit official portal ↗
MalaysiaNational Pharmaceutical Regulatory AgencyVisit official portal ↗
VietnamDrug Administration of VietnamVisit official portal ↗
SingaporeHealth Sciences AuthorityVisit official portal ↗
IndonesiaBadan POMVisit official portal ↗
PhilippinesFood and Drug AdministrationVisit official portal ↗
Live approval data is not connected in this preview. Never interpret absence of a listed medicine as confirmation of approval or prohibition. Scheduled monitoring will prepare dated, source-linked changes for review.

Continue with LINE

Your LINE link opens a personal profile and cannot prefill a direct message. Copy this prepared enquiry, open LINE, then paste it into the chat.